|
 |
European Pharmaceutical Contractor
|
Competitive pressures are forcing pharmaceutical companies to carefully examine the process of drug development. To satisfy shareholders' expectations and survive independently, the modern pharmaceutical company must bring more revenue-generating drugs to market while significantly controlling costs. To meet the challenge, the time is ripe for the clinical trials industry to apply the latest techniques of supply chain or value chain management to the handling of clinical research data.
Supply chain principles, long appreciated by the manufacturing sector, have typically centred on the building of meaningful collaborations among partners and internal groups. More recently, the focus of supply chain implementation has been on electronic solutions to enhance results along the production route that starts with upstream suppliers and extends downstream to completed products and services offered to customers.
Sound planning and management of these steps improves information flow and offers a degree of organisation, consistency and purpose to an otherwise chaotic and unsystematic way of getting things done. Improving the process creates competitive advantage by focusing more resources on producing a better product, faster, and with less waste on the special interests of existing functional silos along the way.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Dr Paul Bleicher, MD, PhD, Founder and Chairman at Phase Forward, Inc
Dr Paul Bleicher, MD, PhD is the Founder and Chairman of Phase Forward, Inc. He has more than 14 years' experience in the design, implementation, and analysis of clinical trials from both the sponsor and clinical investigator perspective. Dr Bleicher has worked as a Director, Early Phase Services at PAREXEL International and at Alpha-Beta Technology Inc where he served as Vice President, Clinical Affairs. He co-founded Phase Forward Incorporated in June 1997. Dr Bleicher received his MD and PhD (Microbiology/Immunology) from the University of Rochester School of Medicine and Dentistry and was trained in Internal Medicine and Dermatology at Harvard Medical School.
Dr Bleicher founded and moderated the Internet-based Clinical Trials Mailing List, is the Technology Columnist for Applied Clinical Trials and serves on the editorial board of Applied Clinical Trials, Research Practitioner, and the Dermatology Online Journal. He is the Chair of the DIA Steering Committee of North America and serves on the DIA Board of Directors.
|
|
|
|
|
|
 |
Industry Events |
 |
Clinical Trials in CNS
25-26 November 2008, Copthorne Tara Hotel, London, UK
SMi present their 7th annual conference… Clinical Trials in CNS 25th to 26th November 2008, Copthorne Tara Hotel, London, UK
More info >> |
|
 |
News and Press Releases |
 |
Aegate Proves Authenticating Drugs at the Point of Dispensing Protects Consumers
More info >> |
|
 |
